Clinical Trial Update: Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing brinzolamide/brimonidine combo to brimonidine alone for preventing intraocular pressure rise after Nd-YAG laser capsulotomy; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Posterior Capsule Opacification

Drugs mentioned

• Brimonidine 0.2% (brimonidine)
• Brinzolamide/brimonidine combination

Snippet

Sponsor: University Hospital of Patras | Conditions: Posterior Capsule Opacification, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2019-07-16